Pathfinder Cell Therapy is developing a novel cell based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ specific cell damage. Pathfinder has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells PCs themselves being incorporated into the new tissue.
Quote | Pathfinder Cell Therapy (OTCMKTS:PFND)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 500 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Pathfinder Cell Therapy (OTCMKTS:PFND)
Message Board Posts | Pathfinder Cell Therapy (OTCMKTS:PFND)
Subject | By | Source | When |
---|---|---|---|
Lots of action in PFND lately. A nearly | buxmaker | investorshub | 06/11/2021 1:49:48 AM |
Resinstated. Anyone got the latest SS or any | strippa | investorshub | 03/10/2021 10:28:34 PM |
no longer exists | 81vette | investorshub | 01/11/2021 2:40:30 PM |
Is there no website? Thanks!!! | Termite7 | investorshub | 01/11/2021 8:18:36 AM |
something coming,demand moving up .0029/.003/.0031+accumulation,ppl don't load | 81vette | investorshub | 09/23/2020 1:44:37 PM |